This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS Acquires Medicare Business for $1.25B

NEW YORK ( TheStreet)-- CVS Caremark (CVS - Get Report) is acquiring Universal American's Medicare's (UAM - Get Report) Medicare Part D business for $1.25 billion.

Universal American shareholders are expected to receive about $12.80 to $13 per share in cash from the acquisition, according to a press release.

CVS shares were down 10 cents at $34.90, and Universal American shares were up $5.79 at $20.40 on the deal.

The deal will more than double the size of CVS Caremark's Medicare Part D program to over 3 million members, according to a company press release. The deal is expected to be a beneficial move for CVS as baby boomers are coming of retirement age and are likely to receive their prescription drug coverage under Medicare plans as health care reform takes place. Medicare Part D is a federal program that subsidizes the prescription drug costs of the program's participants.

CVS said the the deal will be accretive to earnings per share in its first full year. The acquisition is expected to close by the end of the second quarter.

--Written by Maria Woehr in New York.



To contact the writer of this article, click here: Maria Woehr.

To follow the writer on Twitter, go to http://twitter.com/newsgirlmw.

To submit a news tip, send an email to: tips@thestreet.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CVS $101.58 0.00%
UAM $10.85 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs